Given 113's Breakthrough Therapy designation, it is indeed difficult to advance a credible pessimistic scenario for this molecule...although as we have seen, that has not stopped some from trying.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.